The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 61.
233. lappuse
... noted that the process of making the compounds was " a chemical fact involved in the determination of their obviousness " and noted that it was conceded that " the process of producing the claimed compounds would be obvious to the ...
... noted that the process of making the compounds was " a chemical fact involved in the determination of their obviousness " and noted that it was conceded that " the process of producing the claimed compounds would be obvious to the ...
266. lappuse
... noted that to be entitled to his date of con- ception as his priority date , an inventor who is second to reduce to practice must be diligent from that date to the date of reduction to practice . If there is a gap in his diligence , his ...
... noted that to be entitled to his date of con- ception as his priority date , an inventor who is second to reduce to practice must be diligent from that date to the date of reduction to practice . If there is a gap in his diligence , his ...
474. lappuse
... noted that work in perfecting the invention or prepara- tion and filing of a patent application may enable an applicant to bridge the gap between his own reduction to practice and an earlier conception date proved by his opponent ...
... noted that work in perfecting the invention or prepara- tion and filing of a patent application may enable an applicant to bridge the gap between his own reduction to practice and an earlier conception date proved by his opponent ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention